PRIME EUROPEAN THERAPEUTICALS, S.P.A. v. NOVEL LABORATORIES, INC. et al > Summary
Court Case Number 3:17-cv-01944
Filing Date Mar 24, 2017
Court New Jersey District Court
Status Dismissed - Settled
Administrative JudgesMichael A. Shipp, Douglas E. Arpert
Judge Writing the Final DecisionMichael A. Shipp
Defendant
7Plaintiff Attorneys
4Prime Therapeutics LLC
Attorney Name: Todd Avery Rossman
LeClairRyan
AMRI ITALY S.R.L.
Attorney Name: Stephanie L. Jonaitis
Troutman Pepper Hamilton Sanders LLP
Prime Therapeutics LLC
Attorney Name: Michael L. Goldman
LeClairRyan
Prime Therapeutics LLC
Attorney Name: Andrew P. Zappia
LeClairRyan
Defendant Attorneys
13GAVIS Pharmaceuticals
Attorney Name: Eric I. Abraham
Hill Wallack LLP
KISHORE KUMAR HOTHA
Attorney Name: Eric I. Abraham
Hill Wallack LLP
Lupin Atlantis Holdings SA
Attorney Name: Eric I. Abraham
Hill Wallack LLP
Novel Laboratories, Inc. (Lupin)
Attorney Name: Eric I. Abraham
Hill Wallack LLP
GAVIS Pharmaceuticals
Attorney Name: Peter Lambrianakos
Brown Rudnick LLP
KISHORE KUMAR HOTHA
Attorney Name: Peter Lambrianakos
Brown Rudnick LLP
Lupin Atlantis Holdings SA
Attorney Name: Peter Lambrianakos
Brown Rudnick LLP
Novel Laboratories, Inc. (Lupin)
Attorney Name: Peter Lambrianakos
Brown Rudnick LLP
GAVIS Pharmaceuticals
Attorney Name: Christina Saveriano
Hill Wallack LLP
KISHORE KUMAR HOTHA
Attorney Name: Christina Saveriano
Hill Wallack LLP
Lupin Atlantis Holdings SA
Attorney Name: Christina Saveriano
Hill Wallack LLP
Novel Laboratories, Inc. (Lupin)
Attorney Name: Christina Saveriano
Hill Wallack LLP
Salix Pharmaceuticals
Attorney Name: William C. Baton
Saul Ewing LLP
Cause
28:1338 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09186355 | Rifaximin crystalline forms and methods of preparation thereof | Nov 17, 2015 |
| 09018225 | Rifaximin crystalline forms and methods of preparation thereof | Apr 28, 2015 |
| 05000000 | Ethanol production by Escherichia coli strains co-expressing Zymomonas PDC and ADH genes | Mar 19, 1991 |
